235 related articles for article (PubMed ID: 20594860)
21. [Synthesis and antitumor activity of arylsubstituted imidazolin-2-one derivatives].
Cheng YF; Hu YZ; He QJ
Yao Xue Xue Bao; 2005 Aug; 40(8):711-6. PubMed ID: 16268505
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
23. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety.
Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193
[TBL] [Abstract][Full Text] [Related]
25. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.
Saczewski F; Reszka P; Gdaniec M; Grünert R; Bednarski PJ
J Med Chem; 2004 Jun; 47(13):3438-49. PubMed ID: 15189040
[TBL] [Abstract][Full Text] [Related]
27. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytotoxic activities of novel phenacylimidazolium bromides.
Yang XD; Zeng XH; Zhang YL; Qing C; Song WJ; Li L; Zhang HB
Bioorg Med Chem Lett; 2009 Apr; 19(7):1892-5. PubMed ID: 19269816
[TBL] [Abstract][Full Text] [Related]
29. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents.
Rochais C; Lisowski V; Dallemagne P; Rault S
Bioorg Med Chem; 2006 Dec; 14(24):8162-75. PubMed ID: 17011196
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes.
Tailor NK; Boon HL; Sharma M
Eur J Med Chem; 2013 Jun; 64():285-91. PubMed ID: 23644211
[TBL] [Abstract][Full Text] [Related]
33. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties.
Ali AR; El-Bendary ER; Ghaly MA; Shehata IA
Eur J Med Chem; 2014 Mar; 75():492-500. PubMed ID: 24576591
[TBL] [Abstract][Full Text] [Related]
35. Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
Dayam R; Aiello F; Deng J; Wu Y; Garofalo A; Chen X; Neamati N
J Med Chem; 2006 Jul; 49(15):4526-34. PubMed ID: 16854058
[TBL] [Abstract][Full Text] [Related]
36. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole.
Chen W; Yang XD; Li Y; Yang LJ; Wang XQ; Zhang GL; Zhang HB
Org Biomol Chem; 2011 Jun; 9(11):4250-5. PubMed ID: 21505704
[TBL] [Abstract][Full Text] [Related]
40. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
